Louis C. Bock, Director, 10% Owner at Orexigen Therapeutics, Inc. (OREX), sold 30,419 shares at $15.78 ($476K) on 2007-11-16, disclosed to the SEC on 2007-11-19.
Open-market sale of $476k OREX by Director, 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $15.59 | 1,000 | $16K | 3.3% |
| 2 | $15.60 | 3,900 | $61K | 12.8% |
| 3 | $15.61 | 1,314 | $21K | 4.3% |
| 4 | $15.61 | 1,400 | $22K | 4.6% |
| 5 | $15.61 | 2,500 | $39K | 8.2% |
| 6 | $15.62 | 1,986 |
| $31K |
| 6.5% |
| 7 | $15.62 | 1,200 | $19K | 3.9% |
| 8 | $15.63 | 1,500 | $23K | 4.9% |
| 9 | $15.64 | 1,615 | $25K | 5.3% |
| 10 | $15.65 | 1,800 | $28K | 5.9% |
| 11 | $15.66 | 900 | $14K | 3.0% |
| 12 | $15.67 | 1,600 | $25K | 5.3% |
| 13 | $15.68 | 1,200 | $19K | 3.9% |
| 14 | $15.69 | 900 | $14K | 3.0% |
| 15 | $15.70 | 300 | $5K | 1.0% |
| 16 | $15.71 | 700 | $11K | 2.3% |
| 17 | $15.72 | 100 | $2K | 0.3% |
| 18 | $15.72 | 600 | $9K | 2.0% |
| 19 | $15.73 | 200 | $3K | 0.7% |
| 20 | $15.74 | 400 | $6K | 1.3% |
| 21 | $15.75 | 700 | $11K | 2.3% |
| 22 | $15.77 | 800 | $13K | 2.6% |
| 23 | $15.78 | 600 | $9K | 2.0% |
| 24 | $15.79 | 500 | $8K | 1.7% |
| 25 | $15.80 | 800 | $13K | 2.7% |
| 26 | $15.81 | 200 | $3K | 0.7% |
| 27 | $15.82 | 604 | $10K | 2.0% |
| 28 | $15.83 | 500 | $8K | 1.7% |
| 29 | $15.84 | 400 | $6K | 1.3% |
| 30 | $15.85 | 200 | $3K | 0.7% |
| Total | $15.66 avg | 30,419 | $476K | 100% |
| Filing → |
| OREX | BUY | 2014-11-13 | $151K | — | Filing → |
| ZGNX | BUY | 2011-09-22 | $2.5M | — | Filing → |
| HZNP | BUY | 2011-08-04 | $2.8M | — | Filing → |